The impact of LINE-1 retrotransposons on life span, SASP, and telomeres in vivo
LINE-1逆转录转座子对体内寿命、SASP和端粒的影响
基本信息
- 批准号:10212211
- 负责人:
- 金额:$ 33.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-15 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DNA damage accumulates with age in somatic tissues where it contributes to their dysfunction by causing
mutations and cellular senescence. Senescent cells alter tissue microenvironment via secretion of
proinflammatory molecules. DNA damage from endogenous or exogenous sources alone or in combination
with defects in DNA repair pathways often decreases longevity. Long interspersed element-1, L1, an
endogenous retrotransposon, contributes to genomic instability via retrotransposition and the induction of DNA
double-strand breaks. Although endogenous L1 elements are expressed in normal human tissues and cause
DNA damage and cellular senescence, whether L1 affects mammalian life span in vivo is unknown. Among the
500,000 L1 copies present in mammalian genomes only a few L1 loci are capable of causing further DNA
damage. These L1 loci are often polymorphic for their presence in human genomes (pL1s) and are responsible
for the bulk of L1-induced DNA damage. Although some individuals contain two or three times as many of
these pL1 loci than others, the impact of this variation on human life span is not known. Our preliminary data
generated using a transgenic rat model support that a functional L1 transgene increases levels of
proinflammatory markers and shortens average and maximal lifespan in vivo. Our preliminary data also show
that L1 endonuclease cuts telomeric sequences in vitro and may do so in vivo. We hypothesize that
polymorphic L1 loci shorten mammalian lifespan in a dose-dependent manner by causing DNA damage that
induces proinflammatory markers and/or telomere attrition. We will test this hypothesis by using custom
transgenic rats to model variation in the number of functional L1s observed in the human population in order to
study the effect of this variation on longevity in vivo. We will also use DNA samples collected from average and
long-lived (>99 year old) individuals to determine their pL1 content and whether the number of pL1s per
genome correlates with life span. We will use in vitro and tissue culture approaches to determine whether L1
contribution to an increase in SASP markers or telomere attrition could be a plausible mechanism(s) by which
L1 may impact longevity. Combined our findings would provide a currently lacking experimental support for pL1
impact on longevity in vivo and novel mechanisms underlying this effect.
DNA损伤在体细胞组织中随着年龄的增长而累积,该组织会导致其功能障碍。
突变和细胞衰老。衰老细胞通过分泌改变组织微环境
促炎分子。单独或组合内源或外源性来源的DNA损伤
随着DNA修复途径的缺陷,通常会降低寿命。长散布的元素-1,l1,一个
内源性逆转座子,通过逆转录和DNA诱导导致基因组不稳定性
双链断裂。尽管内源性L1元素在正常的人体组织中表达,并导致
DNA损伤和细胞衰老,L1是否影响体内哺乳动物生命跨度是未知的。在
哺乳动物基因组中存在的500,000 L1副本只有几个L1基因座能够引起进一步的DNA
损害。这些L1基因座通常对于它们在人类基因组(PL1)中的存在通常是多态性的,并且是负责的
对于大部分L1诱导的DNA损伤。尽管有些人包含的两到三倍
这些PL1基因座比其他基因座,这种变异对人类寿命的影响尚不清楚。我们的初步数据
使用转基因大鼠模型支持功能性L1转基因会增加的水平
促炎标记并缩短体内平均水平和最大寿命。我们的初步数据也显示
该L1核酸酶在体外切割端粒序列,并可能在体内进行。我们假设这一点
多态L1基因座以剂量依赖性的方式缩短了哺乳动物的寿命,从而导致DNA损伤
诱导促炎标记和/或端粒损耗。我们将使用自定义检验该假设
转基因大鼠以模拟在人口中观察到的功能性L1数量的变化,以便为了
研究这种变异对体内寿命的影响。我们还将使用平均收集的DNA样品,
长寿(> 99岁)的人确定其PL1含量以及是否pl1的数量
基因组与寿命相关。我们将使用体外和组织培养方法来确定L1是否
对SASP标记或端粒损耗增加的贡献可能是一种合理的机制
L1可能会影响寿命。结合我们的发现将为PL1提供目前缺乏实验支持
对体内寿命的影响和这种效果的基础的新型机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Victoria Perepelit...的其他基金
Polymorphic L1 transposons as a Genetic Variable Distinguishing Aggressive from Indolent Prostate Cancer
多态性 L1 转座子作为区分侵袭性前列腺癌和惰性前列腺癌的遗传变量
- 批准号:1026072110260721
- 财政年份:2022
- 资助金额:$ 33.44万$ 33.44万
- 项目类别:
FASEB's Mobile DNA: Evolution, Diversity, and Impact Conference.
FASEB 的移动 DNA:进化、多样性和影响会议。
- 批准号:1031795310317953
- 财政年份:2021
- 资助金额:$ 33.44万$ 33.44万
- 项目类别:
A Forgotten Connection: Retrotransposon contribution to Alzheimer's Disease
被遗忘的联系:逆转录转座子对阿尔茨海默病的贡献
- 批准号:1028855210288552
- 财政年份:2018
- 资助金额:$ 33.44万$ 33.44万
- 项目类别:
The impact of LINE-1 retrotransposons on life span, SASP, and telomeres in vivo
LINE-1逆转录转座子对体内寿命、SASP和端粒的影响
- 批准号:1043186010431860
- 财政年份:2018
- 资助金额:$ 33.44万$ 33.44万
- 项目类别:
The impact of LINE-1 retrotransposons on life span, SASP, and telomeres in vivo
LINE-1逆转录转座子对体内寿命、SASP和端粒的影响
- 批准号:97642279764227
- 财政年份:2018
- 资助金额:$ 33.44万$ 33.44万
- 项目类别:
The impact of advanced parental age on genomic instability in offspring associated with retrotransposon-induced DNA damage
高龄父母对逆转录转座子诱导的 DNA 损伤相关后代基因组不稳定性的影响
- 批准号:92778789277878
- 财政年份:2017
- 资助金额:$ 33.44万$ 33.44万
- 项目类别:
L 1 element as an inrinsic factor of mammalian aging
L 1 元素作为哺乳动物衰老的内在因素
- 批准号:80324368032436
- 财政年份:2008
- 资助金额:$ 33.44万$ 33.44万
- 项目类别:
L 1 element as an inrinsic factor of mammalian aging
L 1 元素作为哺乳动物衰老的内在因素
- 批准号:73847687384768
- 财政年份:2008
- 资助金额:$ 33.44万$ 33.44万
- 项目类别:
相似国自然基金
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
恒星模型中氧元素丰度的变化对大样本F、G、K矮星年龄测定的影响
- 批准号:12303035
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于年龄和空间的非随机混合对性传播感染影响的建模与研究
- 批准号:12301629
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
母传抗体水平和疫苗初种年龄对儿童麻疹特异性抗体动态变化的影响
- 批准号:82304205
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
中国东部地区大气颗粒物的年龄分布特征及其影响因素的模拟研究
- 批准号:42305193
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
The Influence of Lifetime Occupational Experience on Cognitive Trajectories Among Mexican Older Adults
终生职业经历对墨西哥老年人认知轨迹的影响
- 批准号:1074860610748606
- 财政年份:2024
- 资助金额:$ 33.44万$ 33.44万
- 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:1074953910749539
- 财政年份:2024
- 资助金额:$ 33.44万$ 33.44万
- 项目类别:
Understanding the Mechanisms and Consequences of Basement Membrane Aging in Vivo
了解体内基底膜老化的机制和后果
- 批准号:1046501010465010
- 财政年份:2023
- 资助金额:$ 33.44万$ 33.44万
- 项目类别:
Safety and Tolerability of TASIS-Peanut (Targeted Allergen Specific Immunotherapy within the Skin) patch for the Treatment of Peanut Allergy
TASIS-花生(皮肤内靶向过敏原特异性免疫疗法)贴剂治疗花生过敏的安全性和耐受性
- 批准号:1055118410551184
- 财政年份:2023
- 资助金额:$ 33.44万$ 33.44万
- 项目类别:
Sustained eIF5A hypusination at the core of brain metabolic dysfunction in TDP-43 proteinopathies
持续的 eIF5A 抑制是 TDP-43 蛋白病脑代谢功能障碍的核心
- 批准号:1055754710557547
- 财政年份:2023
- 资助金额:$ 33.44万$ 33.44万
- 项目类别: